BASF introduces Kollicoat MAE 100-55 — a new opportunity for the formulation of pharmaceutical enteric film coatings

Enabling direct substitution in commercial enteric pharmaceutical formulations.

Kollicoat MAE 100-55 is the latest addition in BASF’s comprehensive portfolio of functional excipients for Instant & Modified Release. As a new reliable source for this type of coating polymer, Kollicoat MAE 100-55 can directly replace comparable pH >5.5 enteric release materials in commercial formulations. As it matches the release profile and complies with applicable regulatory monographs, Kollicoat MAE 100-55 can be used today without re-registration.

Moreover, the superior size of the dried powder particles delivers dust free handling, thus making operations easy, efficient and clean. Beyond its advantages in handling, Kollicoat MAE 100-55 provides equivalent drug release as existing com­parable products in the market.

“Kollicoat MAE 100-55 extends our offer of pH >5.5 enteric release coatings based on methacrylic acid-ethylacrylate copolymer, providing pharmaceutical manufacturers more flexibility and supply security,” says Kai Sievert, Head of Global Marketing Pharma Solutions at BASF.